Virtual Reality support for Black men newly diagnosed with prostate cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this study, African American/Black men with a new prostate cancer diagnosis are randomized to either delayed-start or early-start access to the PPCD ViRA virtual reality assistant. The ViRA tool uses AI to tailor culturally appropriate psycho-oncology support, social determinants of health navigation, and emotional support delivered via a digital human on multiple devices. The study evaluates the tool’s impact on emotional distress and patient-reported outcomes, and uses mixed methods to explore implementation in clinical, home, and community settings. Primary analyses compare the effectiveness of ViRA in both delivery timelines and settings, while secondary analyses examine feasibility and acceptability.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* African American/Black male
* Diagnosed with CaP within two months
* Be a patient at a participating clinic or affiliates with one of our community sites
* Consent to participating in the study

Exclusion Criteria:

* Do not speak or understand English
* Unable to read or write

Where it's running

• Mayo Clinic in Florida
  Jacksonville, Florida, United States Recruiting

Study contacts

• Principal investigator: Folakemi T. Odedina, PhD — Mayo Clinic
• Study coordinator: Dee Glaser-Boivin
• Email: GlaserBoivin.Denielle@mayo.edu
• Phone: 904-953-4759

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Understanding NK Cell Function in Prostate Cancer Across Races

  This study tests whether natural killer (NK) cells behave differently in prostate cancer patients of diverse racial backgrounds by analyzing blood and tissue samples.

  Recruiting Masonic Cancer Center, University of Minnesota · Minneapolis, Minnesota · NCT07910019

• MRI or CT planning to guide high-dose-rate prostate brachytherapy

  This trial tests whether adding an MRI to CT-based treatment planning for HDR prostate brachytherapy changes urinary side effects in men with localized prostate cancer.

  Recruiting at 3 sites Emory University · Atlanta, Georgia and 2 other locations · NCT07859722

• Targeted Early Detection for Men at High Genetic Risk for Prostate Cancer

  This study tests urinary biomarkers and PSA to see if they can improve early detection for men with a strong family or genetic risk for prostate cancer.

  Recruiting University of Michigan Rogel Cancer Center · Ann Arbor, Michigan · NCT07645391

• Urine and MRI approach to find aggressive prostate cancer early

  This study tests whether a urine test called MPS2, paired with MRI, can better detect aggressive prostate cancer in men 50–75 at risk, possibly reducing unnecessary biopsies.

  Recruiting University of Michigan Rogel Cancer Center · Ann Arbor, Michigan · NCT07526545

• GET FIT Together: a socially enhanced exercise program for older men with prostate cancer

  This program tests whether adding structured social support to supervised online exercise reduces cancer-related loneliness and improves mental and physical health in men 65 and older who have had prostate cancer.

  Recruiting OHSU Knight Cancer Institute · Portland, Oregon · NCT07504835

• Improved MRI methods to distinguish benign from cancerous pelvic findings

  This test tries new deep-learning image-processing methods on MRI scans to get clearer images faster for adults scanned for prostate screening or suspected endometriosis.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07407959

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.